The Hidden Cost of Missed Polyps
Colorectal cancer is the second leading cause of cancer death in the United States, yet it is one of the most preventable cancers when detected at the precancerous polyp stage. Colonoscopy is the gold standard screening tool: a gastroenterologist inserts a camera-equipped scope, visually inspects the colon lining, and removes any suspicious growths before they can become cancerous. The problem is that human visual inspection, even by experienced endoscopists, misses a meaningful fraction of adenomas—precancerous polyps—during a standard colonoscopy procedure. AI-assisted detection systems are now beginning to close that gap.
What Gets Missed and Why
Not all polyps are equally detectable. Pedunculated polyps—the mushroom-shaped growths on stalks—are relatively easy to spot. The harder targets are flat or sessile serrated adenomas that hug the colonic mucosa and can blend with normal tissue folds. These lesions are disproportionately dangerous: sessile serrated lesions follow a faster malignant progression pathway than conventional adenomas and are more likely to develop into the aggressive microsatellite-instable colorectal cancers that are hardest to treat.
Endoscopist fatigue is a genuine factor. A colonoscopy procedure requires sustained visual attention while managing scope mechanics, patient communication, and documentation—a multitasking load that degrades detection performance over the course of a procedure and a clinical day. Back-to-back colonoscopy studies, where a second endoscopist immediately re-examines the colon, find adenoma miss rates of 20-26%, with flat lesions overrepresented among the missed adenomas.
How AI Detection Works
AI-assisted colonoscopy systems display a real-time overlay on the endoscopist's video feed, using computer vision models trained on large datasets of colonoscopy footage to highlight regions that may contain polyps. The best-performing systems produce detection alerts within milliseconds—faster than a human can consciously process and evaluate a region of mucosa. Rather than replacing the endoscopist's judgment, the AI serves as a continuous second set of eyes that never fatigues or gets distracted.
Clinical trials comparing AI-assisted to standard colonoscopy have consistently found that computer-aided detection reduces adenoma miss rates, with the most pronounced effect for small, flat lesions. A meta-analysis of randomized controlled trials found that AI assistance increased adenoma detection rates by approximately 10 percentage points compared to unassisted colonoscopy—a clinically meaningful improvement given that higher detection rates translate directly into lower long-term colorectal cancer incidence in screened populations.
The Specificity Challenge
Early AI detection systems were prone to high false positive rates—flagging normal mucosal folds, bubbles, or artifactual regions as potentially suspicious. High false positive rates create alert fatigue: if the AI alerts every few seconds to something the endoscopist immediately identifies as normal, the alerts lose credibility and practitioners begin ignoring them.
More recent systems have substantially improved specificity through better training datasets and more sophisticated model architectures. Current commercially deployed systems have false positive rates low enough to be clinically workable, though the ongoing challenge is improving sensitivity for the most difficult-to-detect lesions—the flat serrated adenomas that matter most—without reintroducing false positive rates that undermine clinical trust in the system.
Adoption and Reimbursement
AI colonoscopy assistance systems from several vendors have received FDA 510(k) clearance and are being integrated into endoscopy suites at major medical centers and community practices. Reimbursement for AI-assisted colonoscopy through Medicare and commercial insurers has lagged the technology itself, creating economic friction for adoption. However, as the evidence base for detection improvement accumulates and payers recognize the long-term cost implications of prevented colorectal cancers, reimbursement frameworks are gradually adapting.
What Comes Next
The next frontier for AI in endoscopy is polyp characterization—using real-time imaging to distinguish adenomas from hyperplastic polyps that do not require removal, and from malignant lesions that require surgical rather than endoscopic management. Accurate AI characterization could reduce unnecessary polypectomies and enable more targeted follow-up scheduling, making screening colonoscopy both more effective and more efficient. Initial systems are demonstrating promising characterization accuracy in research settings, with commercialization expected to follow detection systems into widespread clinical use over the next several years.
This article is based on reporting by Medical Xpress. Read the original article.
